Logo image of DEX.MI

DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:DEX - IT0005543480 - Common Stock

5.54 EUR
-0.06 (-1.07%)
Last: 12/1/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to DEX. DEX was compared to 35 industry peers in the Household Durables industry. While DEX is still in line with the averages on profitability rating, there are concerns on its financial health. DEX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year DEX was profitable.
DEX had a positive operating cash flow in the past year.
DEX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years DEX had a positive operating cash flow.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

The Return On Assets of DEX (2.20%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 5.87%, DEX is in line with its industry, outperforming 60.00% of the companies in the same industry.
With a Return On Invested Capital value of 3.48%, DEX perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DEX is below the industry average of 10.00%.
The 3 year average ROIC (7.89%) for DEX is well above the current ROIC(3.48%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROIC 3.48%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.97%, DEX is in line with its industry, outperforming 54.29% of the companies in the same industry.
In the last couple of years the Profit Margin of DEX has declined.
DEX has a Operating Margin (2.98%) which is in line with its industry peers.
DEX's Operating Margin has declined in the last couple of years.
The Gross Margin of DEX (37.82%) is comparable to the rest of the industry.
DEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DEX is still creating some value.
DEX has less shares outstanding than it did 1 year ago.
DEX has a better debt/assets ratio than last year.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

DEX has an Altman-Z score of 1.80. This is a bad value and indicates that DEX is not financially healthy and even has some risk of bankruptcy.
DEX has a Altman-Z score (1.80) which is comparable to the rest of the industry.
The Debt to FCF ratio of DEX is 23.75, which is on the high side as it means it would take DEX, 23.75 years of fcf income to pay off all of its debts.
DEX's Debt to FCF ratio of 23.75 is in line compared to the rest of the industry. DEX outperforms 42.86% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that DEX is not too dependend on debt financing.
DEX has a Debt to Equity ratio of 0.34. This is in the better half of the industry: DEX outperforms 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Altman-Z 1.8
ROIC/WACC0.56
WACC6.21%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

DEX has a Current Ratio of 1.06. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
DEX has a worse Current ratio (1.06) than 77.14% of its industry peers.
A Quick Ratio of 0.75 indicates that DEX may have some problems paying its short term obligations.
The Quick ratio of DEX (0.75) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.75
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.75%.
The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
The Revenue has grown by 9.70% in the past year. This is quite good.
The Revenue has been growing by 31.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%

3.2 Future

The Earnings Per Share is expected to grow by 1.45% on average over the next years.
Based on estimates for the next years, DEX will show a small growth in Revenue. The Revenue will grow by 6.12% on average per year.
EPS Next Y-34.28%
EPS Next 2Y-3.67%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue Next Year6.58%
Revenue Next 2Y7.02%
Revenue Next 3Y6.12%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.79, DEX is valued correctly.
Based on the Price/Earnings ratio, DEX is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.46. DEX is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 6.98 indicates a rather cheap valuation of DEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DEX indicates a rather cheap valuation: DEX is cheaper than 85.71% of the companies listed in the same industry.
DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.79
Fwd PE 6.98
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DEX indicates a somewhat cheap valuation: DEX is cheaper than 77.14% of the companies listed in the same industry.
DEX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 41.83
EV/EBITDA 5.4
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.67%
EPS Next 3Y1.45%

0

5. Dividend

5.1 Amount

No dividends for DEX!.
Industry RankSector Rank
Dividend Yield N/A

DEXELANCE SPA

BIT:DEX (12/1/2025, 7:00:00 PM)

5.54

-0.06 (-1.07%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.92%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap149.19M
Revenue(TTM)481.13M
Net Income(TTM)9.48M
Analysts85.71
Price Target9.35 (68.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.84%
PT rev (3m)-18.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-24.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.74%
Valuation
Industry RankSector Rank
PE 16.79
Fwd PE 6.98
P/S 0.31
P/FCF 41.83
P/OCF 14.19
P/B 0.92
P/tB N/A
EV/EBITDA 5.4
EPS(TTM)0.33
EY5.96%
EPS(NY)0.79
Fwd EY14.33%
FCF(TTM)0.13
FCFY2.39%
OCF(TTM)0.39
OCFY7.05%
SpS17.87
BVpS6
TBVpS-2.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.67
Profitability
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROCE 4.78%
ROIC 3.48%
ROICexc 3.89%
ROICexgc 22.15%
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
FCFM 0.74%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Debt/EBITDA 1.49
Cap/Depr 30.32%
Cap/Sales 1.44%
Interest Coverage 250
Cash Conversion 28.23%
Profit Quality 37.61%
Current Ratio 1.06
Quick Ratio 0.75
Altman-Z 1.8
F-Score7
WACC6.21%
ROIC/WACC0.56
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
EPS Next Y-34.28%
EPS Next 2Y-3.67%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%
Revenue Next Year6.58%
Revenue Next 2Y7.02%
Revenue Next 3Y6.12%
Revenue Next 5YN/A
EBIT growth 1Y-62.21%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year18.43%
EBIT Next 3Y13.06%
EBIT Next 5YN/A
FCF growth 1Y-74.95%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y-42.38%
OCF growth 3Y11.3%
OCF growth 5YN/A

DEXELANCE SPA / DEX.MI FAQ

What is the fundamental rating for DEX stock?

ChartMill assigns a fundamental rating of 4 / 10 to DEX.MI.


What is the valuation status of DEXELANCE SPA (DEX.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to DEXELANCE SPA (DEX.MI). This can be considered as Fairly Valued.


What is the profitability of DEX stock?

DEXELANCE SPA (DEX.MI) has a profitability rating of 4 / 10.


What is the valuation of DEXELANCE SPA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DEXELANCE SPA (DEX.MI) is 16.79 and the Price/Book (PB) ratio is 0.92.


What is the earnings growth outlook for DEXELANCE SPA?

The Earnings per Share (EPS) of DEXELANCE SPA (DEX.MI) is expected to decline by -34.28% in the next year.